Kentaro Hashimoto

Nationwide survey of refractory asthma with bronchiectasis by inflammatory subtypes

M. Kaneko, Y. Nakano, T. Hirai, 2022, Respiratory research.

Yes‐associated protein 1 mediates initial cell survival during lorlatinib treatment through AKT signaling in ROS1‐rearranged lung cancer

W. Aoki, R. Itotani, Y. Sakamori, 2022, Cancer science.

Successful oral desensitization with crizotinib after crizotinib-induced hepatitis in an anaplastic lymphoma kinase-rearranged non-small-cell lung cancer patient: A case report.

Young Hak Kim, T. Hirai, H. Nagai, 2017, Molecular and clinical oncology.

Sarcomatoid malignant pleural mesothelioma treated with nivolumab: A case series

A. Yoshizawa, T. Hirai, Y. Sakamori, 2022, Oncology letters.

Artificial intelligence-based analysis of the spatial distribution of abnormal computed tomography patterns in SARS-CoV-2 pneumonia: association with disease severity

T. Hirai, N. Tanabe, Masahiro Shirata, 2024, Respiratory research.